Apellis Pharmaceuticals, Inc. - COM (APLS)

Q4 2022 13F Holders as of 12/31/2022

Type / Class
Equity / COM
Number of holders
241
Total Shares
100M
Shares change
+2.34M
Total reported value, excl. options
$5.19B
Value change
+$67M
Put/Call ratio
0.93
Number of buys
125
Number of sells
-119
Price
$51.71
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.